HOW OMADA WORKS

Omada is virtual care that adapts to real life

Support that’s both human and powered by smart technology—proven to improve population health outcomes.

Many health journeys. One multi-condition partner.

1.4M individual care journeys—one for each member1. The right coach changes everything. Who’s in your corner?

Experience financial benefits and lasting health outcomes

omada-platform-lowered-medical-costs-icon-0122

Lowered Medical Costs

$2,948 in multi-condition

savingsOmada for Diabetes + Hypertension led to $2,948 in gross cost savings for members at year 22

omada-platform-success-based-pricing-icon-0122

Enrollment-Based Pricing

Only pay when members enroll

Omada can be billed directly through medical claims, and you’ll only pay if members enroll.

omada-platform-improved-long-term-health-icon-0122

Improved Long-Term Health

See lives change for the better

Members see average of 5.5% weight loss at 1 year; leading to 50% drop in diabetes risk.3,4

Between-visit virtual care to address expensive chronic conditions found across your population

Virtual Care

  • Prevention and condition management for chronic diseases
  • Access personal health coaches and specialists

Prevention & Weight Health

  • Annual medical costs associated with prediabetes in the US in 2017 is $43.4B*
  • Cost savings per member at year 2 with Omada for prevention: $2,1117

 

Diabetes

  • Estimated costs associated with diabetes in the U.S. is $413B
  • Cost savings per member at year 2 with Omada for diabetes: $2,5407

Hypertension

  • 120M of U.S. adults have hypertension
  • Cost savings per member at year 2 with Omada for hypertension: $2,0747

Musculoskeletal (MSK)

  • Half of U.S. adults deal with MSK pain disorders in a given year
  • Cost savings per member at year 1 with Omada for MSK: $1,2508

Drive meaningful engagement with flexible care

Care that adapts

Care That Adapts

Omada combines human care teams with smart technology to deliver support that’s timely, coordinated, and personal.

Research & Innovation

Activate patients to take care of their own health

Partnership made easy

Partnership Made Easy

Experience proven, reliable partnership with dedicated account teams—integrated where you need us: across 25+ partners, with 200M benefit-eligible lives1.

Product Innovation

Activate patients to take care of their own health

Provider standards

Provider Standards, Proven Outcomes

With Omada’s mutli-condition care model, real evidence supports your investment. We’ve published 30+ peer-reviewed studies, earned national accreditations, and are a HIPAA-covered provider.



Clinical Research

Omada’s improved care pathways drive results

Financial Impact1

Projected Y1 gross savings
$979
Projected Y2 gross savings
$2,011

Clinical Outcomes

1yr Weight Loss
5.5%
Outcomes_Placeholder_300px50px
Learn More

Financial Impact1

Projected Y1 gross savings
$1,121
Projected Y2 gross savings
$2,540

Clinical Outcomes

A1C ↓ (base ≥ 8%) at 12 months
2%
Outcomes_Placeholder_300px50px
Learn More

Financial Impact1

Projected Y1 gross savings
$943
Projected Y2 gross savings
$2,074

Clinical Outcomes

SBP ↓ by
10.3 mmHg
Outcomes_Placeholder_300px50px
Learn More

Clinical Outcomes

showed improvement in their area of concern
93%
program members are highly satisfied with quality of care
99%

Financial Impract 2

Projected Y1 gross savings
$1,250
Outcomes_Placeholder_300px50px
Learn More

Methodology and data from Omada BOB, or from Omada studies available at https://resourcecenter.omadahealth.com/peer-reviewed-studies

August 2024 - New GLP-1 Indications
Omada members get more out of GLP-1s

Our program outcomes show the power of GLP-1s and dedicated behavior change support.

18.4 %

average weight loss among members who stuck with their GLP-1 for 1 year.5

63.2 %

of members maintain or keep losing weight 1 year after stopping a GLP-16

0.8 %

average weight change 1 year after stopping a GLP-16

Learn More

See better member engagement and
long-term health outcomes with Omada.

employer Employerss
healthplan Health Plans
benefit Consultants
we-put-healthcare
we-put-healthcare

Omada Works Different

Contact Sales

References

1. 2025 BoB data

2. Noble M, Chen F, Linke S, Dall TM, Napoleone J. Modeling the economic value of cardiometabolic virtual-first care programs. Am J Manag Care. 2024;30(6 Spec No.):SP430-SP436. doi:10.37765/ajmc.2024.89549

3. Katula JA, Dressler EV, Kittel CA, Harvin LN, Almeida FA, Wilson KE, Michaud TL, Porter GC, Brito FA, Goessl CL, Jasik CB, Sweet CMC, Schwab R, Estabrooks PA. Effects of a Digital Diabetes Prevention Program: An RCT. Am J Prev Med. 2022 Feb 10:S0749-3797(21)00600-0. doi: 10.1016/j.amepre.2021.10.023

4. Maruther NM, Ma Y, Delahanty LM, et al. Early responses to preventative strategies in the diabetes

prevention program. JGenInternMed.2013;28(12):1629–36.

5. Devaraj SM, Chang H, Napoleone JB, Linke S. Weight Health at One Year: Outcomes from Omada's Enhanced GLP-1 Care Track. Omada Health. Published January 8, 2026.

6. Chang H, Devaraj SM, Naqvi JB, Napoleone J, Linke S. Weight maintenance is possible after GLP-1s—with the right support. Omada Health. Published September 8, 2025.

Images used are not real members. Testimonials are based on members’ real experiences and individual results. We do not claim that these are typical results that members will achieve. Results may vary.

The no cost CGM sensors exclude Medicare, Medicaid, and other government payers. The Abbott FreeStyle Libre 14 day system is available to eligible participants with a valid prescription and compatible smartphone. Setup is required for continuous glucose monitoring. The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a finger stick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

Image Disclaimer: Images, including apps, do not reflect real members or information about a specific person.

 

 

 

 

*American Diabetes Association, Dall, TM, Yang, W, Gillespie, K, et al., The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes, Diabetes Care, September 2019; 42(9):1661-1668

7. Noble M, Chen F, Dall T, Linke S, Napoleone J. 2023. The Economic Value of Cardiometabolic Digital Health Programs. American Journal of Managed Care. Manuscript Accepted.

Omada costs savings data over time is based on a Markov model simulation where we have a clinical outcome data point at both baseline and in the 6-12 month time period. This represents 65% of our total member population for Prevention, 62% for Diabetes, 66% for Hypertension and 72% for Diabetes + Hypertension.

8. Chen F, Siego CV, Jasik CB, et al. The Value of Virtual Physical Therapy for Musculoskeletal Care. American Journal of Managed Care. 2023;29(6):e169-e175. doi.org/10.37765/ajmc.2023.89375

Year 1 savings based on average savings for members that receive PT guided care. Model based on data from nationally representative sample of commercially insured patients from 2018 Medical Expenditure Panel Survey.

Images used are not real members. Testimonials are based on members’ real experiences and individual results. We do not claim that these are typical results that members will achieve. Results may vary.

The no cost CGM sensors exclude Medicare, Medicaid, and other government payers. The Abbott FreeStyle Libre 14 day system is available to eligible participants with a valid prescription and compatible smartphone. Setup is required for continuous glucose monitoring. The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a finger stick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.